These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 35421118)
1. Cardiovascular risk factors, ethnicity and infection stone are independent factors associated with reduced renal function in renal stone formers. Choy SH; Nyanatay SA; Sothilingam S; Malek R; J R S; Toh CC; Sundram M; Md Yusoff NA; Nagappan P; Kamaruzaman S; Yeoh WS; Ong TA; Lim J PLoS One; 2022; 17(4):e0265510. PubMed ID: 35421118 [TBL] [Abstract][Full Text] [Related]
2. Novel evaluation of nephrolithiasis as a complication of gout: a cross-sectional study using helical computerized tomography. Shimizu T; Kitada H; Umeyama M; Hori H; Takasaki N J Urol; 2013 May; 189(5):1747-52. PubMed ID: 23159585 [TBL] [Abstract][Full Text] [Related]
3. Characteristics of gout patients according to the laterality of nephrolithiasis: A cross-sectional study using helical computed tomography. Shimizu T; Hori H; Umeyama M; Shimizu K Int J Rheum Dis; 2019 Apr; 22(4):567-573. PubMed ID: 30485677 [TBL] [Abstract][Full Text] [Related]
4. Impact of nephrolithiasis on kidney function. Sigurjonsdottir VK; Runolfsdottir HL; Indridason OS; Palsson R; Edvardsson VO BMC Nephrol; 2015 Aug; 16():149. PubMed ID: 26316205 [TBL] [Abstract][Full Text] [Related]
5. Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers. Kittanamongkolchai W; Mara KC; Mehta RA; Vaughan LE; Denic A; Knoedler JJ; Enders FT; Lieske JC; Rule AD Clin J Am Soc Nephrol; 2017 Mar; 12(3):476-482. PubMed ID: 28148559 [TBL] [Abstract][Full Text] [Related]
6. Effects of visceral fat area and other metabolic parameters on stone composition in patients undergoing percutaneous nephrolithotomy. Zhou T; Watts K; Agalliu I; DiVito J; Hoenig DM J Urol; 2013 Oct; 190(4):1416-20. PubMed ID: 23685097 [TBL] [Abstract][Full Text] [Related]
7. Who makes uric acid stones and why--observations from a renal stones clinic. Stansbridge EM; Griffin DG; Walker V J Clin Pathol; 2013 May; 66(5):426-31. PubMed ID: 23454727 [TBL] [Abstract][Full Text] [Related]
8. Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes. Bobulescu IA; Maalouf NM; Capolongo G; Adams-Huet B; Rosenthal TR; Moe OW; Sakhaee K Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1498-503. PubMed ID: 24026180 [TBL] [Abstract][Full Text] [Related]
9. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F; Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027 [TBL] [Abstract][Full Text] [Related]
10. Kidney stone formation is positively associated with conventional risk factors for coronary heart disease in Japanese men. Ando R; Nagaya T; Suzuki S; Takahashi H; Kawai M; Okada A; Yasui T; Kubota Y; Umemoto Y; Tozawa K; Kohri K J Urol; 2013 Apr; 189(4):1340-6. PubMed ID: 23159273 [TBL] [Abstract][Full Text] [Related]
11. Increased risk of chronic kidney disease in uric acid stone formers with high neutrophil-to-lymphocyte ratio. Tung HT; Liu CM; Huang HS; Lu ZH; Liu CJ Sci Rep; 2023 Oct; 13(1):17686. PubMed ID: 37848540 [TBL] [Abstract][Full Text] [Related]
12. Transient renal impairment in the absence of pre-existing chronic kidney disease in patients with unilateral ureteric stone impaction. Kim HY; Choe HS; Lee DS; Yoo JM; Lee SJ Urolithiasis; 2017 Jun; 45(3):249-254. PubMed ID: 27388450 [TBL] [Abstract][Full Text] [Related]
13. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi]. Hess B Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986 [TBL] [Abstract][Full Text] [Related]
14. Urinary metabolic profile and stone composition in kidney stone formers with and without heart disease. Bargagli M; Moochhala S; Robertson WG; Gambaro G; Lombardi G; Unwin RJ; Ferraro PM J Nephrol; 2022 Apr; 35(3):851-857. PubMed ID: 34152561 [TBL] [Abstract][Full Text] [Related]
15. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers. Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420 [TBL] [Abstract][Full Text] [Related]
16. Risk of ESRD and Mortality in Kidney and Bladder Stone Formers. Dhondup T; Kittanamongkolchai W; Vaughan LE; Mehta RA; Chhina JK; Enders FT; Hickson LJ; Lieske JC; Rule AD Am J Kidney Dis; 2018 Dec; 72(6):790-797. PubMed ID: 30146423 [TBL] [Abstract][Full Text] [Related]
17. Obesity and urolithiasis: evidence of regional influences. Trinchieri A; Croppi E; Montanari E Urolithiasis; 2017 Jun; 45(3):271-278. PubMed ID: 27488444 [TBL] [Abstract][Full Text] [Related]
18. The Analysis of Risk Factors for Hemorrhage Associated with Minimally Invasive Percutaneous Nephrolithotomy. Meng X; Bao J; Mi Q; Fang S Biomed Res Int; 2019; 2019():8619460. PubMed ID: 30834279 [TBL] [Abstract][Full Text] [Related]
19. Association of Impaired Renal Function With Changes in Urinary Mineral Excretion and Stone Composition. Patel PM; Kandabarow AM; Druck A; Hart S; Blackwell RH; Kadlec A; Farooq A; Turk TMT; Baldea KG Urology; 2020 Jul; 141():45-49. PubMed ID: 32294484 [TBL] [Abstract][Full Text] [Related]
20. Causes and consequences of kidney loss in patients with nephrolithiasis. Worcester E; Parks JH; Josephson MA; Thisted RA; Coe FL Kidney Int; 2003 Dec; 64(6):2204-13. PubMed ID: 14633144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]